Houston, TX · Founded 2020 · Privately Held (backing)
Developer of plant-based medicines intended to treat a wide range of infectious and noninfectious diseases. Stramsen Biotech is based in Houston, TX and was founded in 2020. Its last reported valuation was $807 million in Oct 2023. It has raised $35 million.
Last reported valuation
$807.0M
Oct 2026
Priced at
—
Total raised
$35.0M
Last round
—
Cap table — not yet on record
Stramsen Biotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stramsen Biotech with a free account
·Watch Stramsen Biotech: the Monday email on marks, rounds and moves
